Baby Mayra
Mayra’s Journey: A Fight for Every Breath
Mayra, a two-month-old baby girl, was diagnosed with a Congenital Heart Disease (CHD) even before her birth during the antenatal stage. From her earliest days, her parents noticed worrying signs—bluish discoloration of the skin and low oxygen levels—indicating a serious heart condition.
Concerned, they took her to Ambedkar Hospital for evaluation. Detailed investigations, including echocardiography, confirmed a complex diagnosis: Tricuspid Atresia, a critical congenital defect requiring urgent medical intervention.
A Race Against Time
Understanding the severity of her condition and the need for specialized care, doctors referred Mayra’s case to the Child Heart Foundation (CHF).
At CHF, a second detailed echocardiography reaffirmed the diagnosis and the urgency of treatment. Doctors recommended PDA stenting as the immediate course of action to stabilize her condition and improve oxygenation.
For her parents, this was an overwhelming moment—but hope was close.
The Life-Saving Procedure
On 30th January 2026, Mayra was admitted to Indraprastha Apollo Hospital, Delhi.
The very next day, on 31st January 2026, she successfully underwent PDA stenting. The procedure was completed without complications, marking a crucial step in her treatment journey.
A New Beginning
Today, Mayra is stable and on the path to recovery, giving her family renewed hope for a brighter future.
This life-saving intervention was made possible with the generous support of Mankind Pharma and the continuous efforts of the Child Heart Foundation.
With hearts full of gratitude, Mayra’s parents thank Mankind Pharma and CHF for standing by them during their most critical time—and for giving their daughter a fighting chance at life.